title: A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
authors.affiliation: Service de Néphrologie Hôpital, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Thervet
authors.forename: E
authors.initials: E
authors.lastname: Morelon
authors.forename: D
authors.initials: D
authors.lastname: Ducloux
authors.forename: L
authors.initials: L
authors.lastname: Bererhi
authors.forename: L H
authors.initials: LH
authors.lastname: Noël
authors.forename: A
authors.initials: A
authors.lastname: Janin
authors.forename: J
authors.initials: J
authors.lastname: Bedrossian
authors.forename: S
authors.initials: S
authors.lastname: Puget
authors.forename: J M
authors.initials: JM
authors.lastname: Chalopin
authors.forename: M
authors.initials: M
authors.lastname: Mihatsch
authors.forename: C
authors.initials: C
authors.lastname: Legendre
authors.forename: H
authors.initials: H
authors.lastname: Kreis
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine